RxSight, Inc.
RXST · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -9.8% | -11.2% | -5.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 79.9% | 74.9% | 74.8% | 71.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -29.5% | -32.6% | -19.5% | -13.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -32.4% | -35% | -21.6% | -14.8% |
| EPS Diluted | -0.24 | -0.29 | -0.2 | -0.15 |
| % Growth | 17.2% | -45% | -33.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |